Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martha Brainard
Institution:
Dana-Farber Cancer Institute
Observed institutions:
Harvard University,
Dana-Farber Cancer Institute,
Dana-Farber/Harvard Cancer Center
OpenAlex ID:
A5063809123
Cytokine changes during immune-related adverse events and corticosteroid treatment in melanoma patients receiving immune checkpoint inhibitors
2021
·
Kevin Tyan
, Joanna Baginska
, et al.
·
Cancer Immunology Immunotherapy
·
64
Standardized 11-color flow cytometry panel for the functional phenotyping of human T regulatory cells
2020
·
Claire Manuszak
, Martha Brainard
, et al.
·
Journal of Biological Methods
·
9
Profiling of Natural Killer Interactions With Cancer Cells Using Mass Cytometry
2023
·
Margaret Hallisey
, Jenna Dennis
, et al.
·
Laboratory Investigation
·
8
PDF
Simplified mass cytometry protocol for in-plate staining, barcoding, and cryopreservation of human PBMC samples in clinical trials
2022
·
Charlotte Abrecht
, Margaret Hallisey
, et al.
·
STAR Protocols
·
6
PDF
648 Cytokine changes during immune-related adverse events and steroid treatment in melanoma patients receiving immune checkpoint inhibitors
2020
·
Kevin Tyan
, Joanna Baginska
, et al.
·
Regular and Young Investigator Award Abstracts
·
4
Abstract 6397: Immune profiling for improving responsiveness to ipilimumab plus nivolumab checkpoint blockade treatment in patients with metastatic melanoma
2024
·
Joanna Baginska
, Jiajia Chen
, et al.
·
Cancer Research
Mass Cytometry – Based Cytotoxicity Assay for Profiling Natural Killer Cells
2021
·
Elizabeth P. Gabriel
, Alyssa Masciarelli
, et al.
·
SSRN Electronic Journal
808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF)
2020
·
Osama Rahma
, Joanna Baginska
, et al.
Show more works
View as search
Works count:
8
Citation count:
91
H-index:
4
I10-index:
1
Year
Topic
Type